SHIRE LICENSES AGRYLIN TO KIRIN PHARMACEUTICAL IN JAPAN.

From: Worldwide Biotech | Date: February 1, 2004 | Copyright information

Shire Pharmaceuticals Group plc (Nasdaq: SHPGY; LSE: SHP; TSX: SHQ), Basingstoke, England, has been signed an agreement with a leading haematology specialty company, the Pharmaceutical Division of Kirin Brewery Company Ltd, granting the rights to develop, register, formulate, package, label, market and sell AGRYLIN (anagrelide hydrochloride) in Japan, the world's second largest pharmaceuticals market.

This transaction is further evidence of Shire's recently announced st...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and journal articles from HighBeam Research

MASTER of the SONG: Buffalo Philharmonic Orchestra honors native David Shire with an entire evening devoted to his music.
Buffalo News (Buffalo, NY) ; ... his voice. You're always grateful. e-mail: mkunz@buffnews.com Copyright (c) 2007, The Buffalo News, N.Y. Distributed by McClatchy-Tribune Business News. For reprints, email tmsreprints@permissionsgroup.com, call 800-374-7985 or 847-635-6550, send ...
SHIRE PHARMACEUTICALS: A STUDY IN EXPONENTIAL GROWTH
The Scientist ; It's not every company that can go from $7 million in revenues to more than $1.7 billion in 10 years, but that's precisely what Shire Pharmaceuticals, whose hub lies in Wayne, Pa., accomplished in the last decade. The key to its success? Seizing opportunities that Big Pharma ignored. Shire was
Sequel spotlight shines on Talia Shire's return
Chicago Sun-Times ; LOS ANGELES She has been the archetypal Italian woman both on- and off-screen for almost two decades. In fact, she has so completely absorbed this image that no one knows exactly where Talia Shire the actress leaves off and Talia Shire the person begins. First there is the make-believe Shire who
SHIRE EXPANDING, HIRING 100 AT CAMBRIDGE UNIT
The Boston Globe ; Shire PLC said it is hiring 100 people to work at its Human Genetic Therapies division in Cambridge, expanding the number of employees at the former Transkaryotic Therapies Inc. by 25 percent. The company is adding salespeople, scientists, manufacturing staff, and general corporate staff, said
SHIRE GROUP DRUG FIRM TO ACQUIRE CONTRACTOR.(BUSINESS)
The Cincinnati Post (Cincinnati, OH) ; Byline: Post staff report British-based Shire Pharmaceuticals Group, which has its U.S. headquarters in Florence, Ky., is acquiring one of its U.S.-based contractors. Shire announced Friday that it is acquiring Atlantic Pharmaceutical Services Inc., which has facilities in Maryland, for about $17
Shire under pressure to renew Medeva bid
The Independent - London ; SHIRE PHARMACEUTICALS, the biotechnology group capitalised at pounds 830m, is thought to be on the verge of a bid for its smaller rival Medeva to form a pharmaceuticals company capitalised at almost pounds 1.4bn. Medeva's shares added almost 19.5p, or 17 per cent, yesterday, at 135.5p. Shire's
Shire flourishes after fresh start ; MU gymnast rediscovers love of sport.
Columbia Daily Tribune ; Sarah Shire was packed and ready to go, ready to bury her gymnastics career in Utah and leave both state and sport behind. Her freshman season with the national powerhouse Utes had left Shire with multiple broken bones and, worse, a distaste for the sport that had defined her life. That explains
Shire falls 16% on takeover of Canadian BioChem group
The Independent - London ; SHIRE PHARMACEUTICALS, the UK's fourth-largest drugs firm, saw its shares plunge 16 per cent yesterday after it unveiled the takeover of BioChem Pharma, an underperforming Canadian pharmaceuticals company, in an all-paper deal valuing the enlarged group at pounds 5.3bn. Shire said the aim of the
Deal and strong sales make Shire a healthy choice.
The Mail on Sunday (London, England) ; SHARES in Shire Pharmaceuticals, Britain's third-largest drugs company, have experienced a turbulent couple of months since it announced the takeover of Canadian rival BioChem Pharma in December. Fears that Shire was overpaying by splashing out [pound]2.8 billion for BioChem dragged the share price
Outlook: Shire's biotech takeover deserves some support
The Independent - London ; Shire's biotech takeover deserves some support NOT MANY deals get a resoundingly positive response in today's uncertain markets, but they don't come much more negative than the near 16 per cent clobbering inflicted on the share price of Shire Pharmaceutical Group after the biotech darling announced